However, despite growing insights into the biological roles of TRIM6 in systemic diseases and solid tumors, its expression profile, functional mechanisms, and prognostic relevance in AML remain largely unexplored, representing a significant gap in current research. Here, TRIM6 is linked to acute myeloid leukemia.